The prevalence and predictors of disordered eating in women with coeliac disease by Satherley, Rose-Marie et al.
 
 
The prevalence and predictors of disordered eating
in women with coeliac disease
Satherley, Rose-Marie; Higgs, Suzanne; Howard, Ruth
DOI:
10.1016/j.appet.2016.07.038
License:
Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Satherley, R-M, Higgs, S & Howard, R 2016, 'The prevalence and predictors of disordered eating in women with
coeliac disease', Appetite, vol. 107, pp. 260-267. https://doi.org/10.1016/j.appet.2016.07.038
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
DISORDERED EATING IN COELIAC DISEASE  
1 
 
The Prevalence and Predictors of Disordered Eating in Women with Coeliac Disease 1 
Purpose: The need for dietary management in coeliac disease may lead to the development 2 
of disordered eating. This study examined the prevalence of disordered eating and factors 3 
predicting disordered eating in women with coeliac disease, compared with other dietary-4 
controlled conditions.  5 
Methods: A cross-sectional, online survey assessing psychological well-being, disordered 6 
eating behaviours (Eating Attitudes Test 26 (EAT-26); Binge Eating Scale (BES)) was 7 
distributed using online forums, to those with coeliac disease (N=157), inflammatory bowel 8 
disease (N=116), type two diabetes (N=88) and healthy controls (N=142). Hierarchical 9 
regressions were conducted to explore and compare the predictors of EAT-26 and BES 10 
scores across all groups. Within the coeliac disease group, a cluster analysis was conducted 11 
to examine types of disordered eating.  12 
Results: Higher EAT-26 scores were found in those with coeliac disease and inflammatory 13 
bowel disease compared with healthy controls and type two diabetes; participants with a 14 
chronic health condition had higher BES than healthy control participants. The factors 15 
associated with EAT-26 scores differed across the dietary-controlled health conditions, with 16 
dietary management being important for those with coeliac disease. Psychological distress 17 
was associated with binge-eating behaviour across all groups.  Cluster analyses found two 18 
types of disordered eating in coeliac disease; a binge eating type and a restrictive type.  19 
Conclusions: Disordered eating attitudes and behaviours are more prevalent in participants 20 
with chronic health conditions relative to healthy controls. The presence of binge eating 21 
behaviours in coeliac disease may be related to non-coeliac disease specific factors such as 22 
DISORDERED EATING IN COELIAC DISEASE  
2 
 
the distress associated with dietary-controlled illness. EAT-26 scores in coeliac disease are 23 
associated with disease specific factors, unique to following the gluten-free diet. These 24 
factors are important for identifying and supporting those with coeliac disease and 25 
disordered eating.  26 
Introduction 27 
Coeliac disease is an autoimmune condition characterised by damage to the small intestine 28 
following the ingestion of the protein gluten (NICE, 2015). The condition is managed by a 29 
life-long gluten-free diet, requiring the exclusion of wheat, rye, barley and sometimes oats 30 
(GFD; Di Sabatino & Corazza, 2009; NICE, 2015). The GFD is the only treatment for coeliac 31 
disease; it is effective in reversing intestinal damage and is necessary to avoid complications 32 
such as osteoporosis and gastrointestinal cancers (Valdimarsson, Toss, Ross, Lofman & 33 
Strom, 1994). However, management of a dietary-controlled health condition, such as 34 
coeliac disease, creates pressures that may harm one’s relationship with food and have 35 
been associated with an increased prevalence of disordered eating attitudes and behaviours 36 
(Quick, Byrd-Bredbenner & Neumark-Sztainer, 2013). Disordered eating describes a 37 
spectrum of eating behaviours, which can range from clinical eating disorders to skipping 38 
meals, binge eating, restricting certain food types or fasting (Grilo, 2006).  39 
The risk of developing disordered eating behaviours increases with psychological distress, 40 
which frequently occurs in a range of chronic health conditions (Quick, Byrd-Bredbenner & 41 
Neumark-Sztainer, 2013). Furthermore there is an increased risk of developing disordered 42 
eating in individuals diagnosed with a chronic health condition during puberty, when their 43 
body shape is already changing (Smith, Latchford, Hall & Dickson, 2008). These factors are 44 
common across all chronic health conditions. For individuals with coeliac disease, the need 45 
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to monitor the gluten content of food, combined with fears about the effectiveness of their 46 
GFD and concerns about the prevention of gastrointestinal symptoms, may additionally 47 
contribute to increased risk of disordered eating (Arigo, Anskis & Smyth, 2012; Karwautz et 48 
al., 2008).  49 
To date, there have been few studies of the prevalence of disordered eating in coeliac 50 
disease. The results of two cross-sectional surveys suggest that between 22% and 29% of 51 
individuals with coeliac disease score above the clinical cut-offs on measures assessing 52 
Anorexia and Bulimia Nervosa (Arigo, Anskis & Smyth, 2012; Karwautz et al., 2008).  Poor 53 
dietary management, psychological distress and physical symptoms related to coeliac 54 
disease were frequent in those with disordered eating attitudes and behaviours (Arigo, 55 
Anskis & Smyth, 2012; Karwautz et al., 2008; Wagner et al., 2015), however, the absence of 56 
a control group means that it is impossible to determine if the disordered eating is related 57 
to the coeliac diagnosis or if it results from the nonspecific burden of a chronic health 58 
condition. These factors are essential to understand the mechanisms behind disordered 59 
eating in coeliac disease. 60 
Case studies offer an understanding of the complex relationship between disordered eating 61 
and coeliac disease (Leffler et al., 2007; Ricca et al., 2000; Yucel, Ozbey, Demir, Polat & 62 
Yager, 2006). Yucel et al., (2006) suggested that the long-term dietary restraint, necessary in 63 
coeliac disease, might contribute to disordered eating attitudes and behaviours whereas 64 
Leffler et al., (2007) suggested that problems with maintaining the GFD may be associated 65 
with disordered eating attitudes and behaviours. However, to fully understand the extent of 66 
this problem and to understand the mechanisms behind disordered eating in coeliac 67 
disease, larger sample sizes are required. 68 
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Prior to diagnosis, some individuals with coeliac disease experience severe gastrointestinal 69 
symptoms, which may contribute to the development of disordered eating attitudes and 70 
behaviours (Arigo, Anskis & Smyth, 2012; Satherley, Howard & Higgs, 2014). Although most 71 
individuals will experience clinical remission on the GFD, some will continue to experience 72 
gastrointestinal symptoms, which may result from refractory coeliac disease where the 73 
individual is not responsive to the GFD (Daum, Cellier & Mulder, 2005). Alternatively, 74 
Midhagen and Hallert (2003) suggested that the nutritional composition of the GFD might 75 
be responsible for persistent gastrointestinal symptoms, whereas Nachman et al, (2010) 76 
suggested this results from poor dietary management. Untreated gastrointestinal symptoms 77 
may trigger an aversion to food, which can influence disordered eating attitudes and 78 
behaviours (Berstein & Borson, 1986). Gastrointestinal symptoms have been associated with 79 
food aversion in a variety of chronic health conditions including cancer (Coa et al., 2015), 80 
autism (Nadon, Feldman, Dunn & Gisel, 2011) and gastroparesis (a condition characterised 81 
by delayed gastric emptying; NIDDK Gastroparesis Clinical Research Consortium). However, 82 
the role of gastrointestinal symptoms in coeliac disease and the development of disordered 83 
eating has received little attention.  84 
Gastrointestinal symptoms and dietary management are closely associated via a 85 
bidirectional relationship, where good dietary management is associated with fewer and/or 86 
less severe gastrointestinal symptoms, and poor dietary management is associated with 87 
increased/more severe gastrointestinal symptoms (Murray, Eason, Clearman & Mitros, 88 
2003). The associations between gastrointestinal symptoms and disordered eating attitudes 89 
and behaviours may be explained by the deliberate consumption of gluten in those 90 
diagnosed with coeliac disease; Leffler et al., (2007) described cases in which individuals 91 
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would consume gluten in order to encourage gastrointestinal symptoms to promote weight 92 
loss. However, this phenomenon has only been described in case studies and it is not clear 93 
how these findings will generalise to larger samples. Misuse of dietary regimens has been 94 
reported in diabetes (Young-Hyman & Davis, 2010) and there is potential for this to occur in 95 
coeliac disease.  96 
Satherley, Howard and Higgs’ (2014) developed a two-path, theoretical model of disordered 97 
eating in gastrointestinal disease, suggesting disordered eating differs depending on beliefs 98 
about the disease and dietary management. The first pathway describes individuals who 99 
experience extreme anxiety around unfamiliar foods and/or overestimate the negative 100 
consequences associated with their condition. These individuals may fear food prepared 101 
outside of their control, and cope with this by eating a limited variety of foods. The second 102 
pathway describes individuals who experience weight gain after commencing their 103 
prescribed dietary regimen and may use techniques to reverse this weight gain. Not all 104 
individuals with coeliac disease will experience weight gain after commencing the GFD; 105 
however, good dietary management has been associated with a post-diagnosis increase in 106 
weight (Kabbani et al., 2012). Prior to coeliac diagnosis, individuals may present as 107 
underweight, meaning that increased weight is an indicator of recovery of the intestine, 108 
however, for some individuals this weight change may be negatively interpreted and trigger 109 
disordered eating. These individuals may recognise the association between weight gain and 110 
the GFD and aim to reduce their weight gain through poor dietary management (Leffler et 111 
al., 2007). The model proposed by Satherley, Howard and Higgs (2014) has the potential to 112 
help us to interpret and understand the relationships between disordered eating and coeliac 113 
disease by testing specific hypotheses.  114 
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This study is the first to apply Satherley, Howard and Higgs’ (2014) model of disordered 115 
eating in gastrointestinal disease to coeliac disease. Given the limitations of prior studies, 116 
this study assessed the prevalence, predictors and types of disordered eating in coeliac 117 
disease compared to other dietary-controlled conditions. Individuals with coeliac disease, 118 
who follow a strict GFD, were compared to those with inflammatory bowel disease and type 119 
two diabetes (both of which have dietary components to their management) and healthy 120 
controls. Dietary management in inflammatory bowel disease and type two diabetes is 121 
unlike that for coeliac disease as it is less strict and regimented when compared to the GFD 122 
and other medical interventions may be required, which is generally not the case in coeliac 123 
disease. Individuals with inflammatory bowel disease experience gastrointestinal symptoms 124 
associated with the ingestion of certain restricted foods, which can differ between patients, 125 
but will avoid these trigger foods during a flare-up and may use medical or surgical 126 
approaches to manage flare-ups (NICE, 2015); those with type two diabetes do not have 127 
gastrointestinal symptoms as a feature of their diagnosis and do not avoid particular food 128 
types, but will follow a balanced diet with an emphasis on consuming high fibre and low-129 
glycaemic index foods. This may be combined with blood glucose monitoring and insulin 130 
injections (NICE, 2009). These control groups allowed us to explore the role of nonspecific 131 
factors common to all dietary-controlled conditions (years with condition, psychological 132 
distress), factors common to gastrointestinal disease (gastrointestinal symptoms) and 133 
factors unique to the coeliac disease diagnosis (GFD management). The most common types 134 
of disordered eating patterns related to Binge Eating, Anorexia Nervosa and Bulimia 135 
Nervosa, were assessed (NHS, 2015).  136 
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We anticipated the following: 1) individuals with dietary-controlled conditions (coeliac 137 
disease, inflammatory bowel disease and type two diabetes) would score greater on 138 
disordered eating measures than healthy controls; 2) psychological distress, a nonspecific 139 
factor, would be associated with disordered eating across all groups; 3) in those with 140 
gastrointestinal disorders (inflammatory bowel disease and coeliac disease), factors unique 141 
to these conditions (gastrointestinal symptoms) would explain additional variance in 142 
disordered eating scores; 4) additional variance in disordered eating would be explained by 143 
dietary-management in coeliac disease and 5) based on the theoretical model of disordered 144 
eating (Satherley, Howard & Higgs, 2014), we expected two types of disordered eating to be 145 
present in coeliac disease..  One group of disordered eaters was expected to show good 146 
dietary self-management and few gastrointestinal symptoms, associated with increased 147 
anxiety around new foods. The second group was expected to have poor dietary 148 
management and experience increased gastrointestinal symptoms, associated with gluten 149 
ingestion. 150 
Methods 151 
The cross-sectional survey was conducted between June and December 2014. Individuals 152 
living in the United Kingdom, aged between 18-69 years and who self-reported a biopsy-153 
confirmed diagnosis of coeliac disease, type two diabetes or inflammatory bowel disease, 154 
were eligible to participate. Healthy controls with no reported health conditions or food 155 
allergies were also recruited. Participants were excluded if 1) they reported having a dietary-156 
controlled condition other than coeliac disease, type two diabetes or inflammatory bowel 157 
disease (e.g. cystic fibrosis, type I diabetes) and 2) if they had any other food allergies.  158 
Individuals with type two diabetes were required to be following a prescribed dietary 159 
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regimen as a part of their treatment programme and individuals with coeliac disease were 160 
required to self-report a biopsy confirmed diagnosis.  161 
Participants were recruited through adverts on online support forums (e.g. Facebook) and 162 
through Coeliac UK, the main charity supporting people with coeliac disease in the UK. 163 
Interested individuals were directed to an online survey to complete the following 164 
questionnaires. Men were recruited but only 14 took part, so this data was not analysed.  165 
Measures 166 
Demographic and General Health Information 167 
For participants with type two diabetes, inflammatory bowel disease and coeliac disease, 168 
information was gathered on demographics, information relating to diagnosis (method of 169 
diagnosis, date of diagnosis, dietary management) and health status (allergies, medication). 170 
For individuals with coeliac disease, diagnostic method was assessed on a 3 item scale 171 
including 1) biopsy provided diagnosis; 2) blood test; 3) I diagnosed myself based on dietary 172 
changes, and dietary self-management was rated on a 5-point Likert scale, in response to 173 
the question “In general, how strictly do you maintain a gluten free diet?” ranging from ‘1) 174 
All of the time’; 2) ‘Most of the time’; 3) ‘Some of the time’; 4) ‘Now and then’; 5) ‘Not at all’ 175 
(Ford, Howard & Oyebode, 2012). For those with inflammatory bowel disease and type two 176 
diabetes dietary self-management was also rated on a 5-point Likert scale but the item was 177 
phrased “In general, how strictly do you maintain your prescribe dietary-regimen?” 178 
The presence of gastrointestinal symptoms was assessed using the Illness Perception 179 
Questionnaire Revised (IPQ-R; Moss-Morris et al., 2002). Participants are asked to rate 180 
whether they have experienced a symptom since their diagnosis (yes/no). A total 181 
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gastrointestinal symptom was calculated by adding up the total of gastrointestinal 182 
symptoms (nausea, weight loss, upset stomach, abdominal pain, bloating, excessive wind, 183 
constipation, indigestion) experienced in the last four weeks, providing a score between 0 184 
and 8, with 8 indicating a greater number of gastrointestinal symptoms.   185 
The IPQ-R also measures an individual’s perceptions of illness, the cause of their illness and 186 
their personal views of the illness. Only those with coeliac disease only completed this 187 
questionnaire but the results are not reported here, as they are not directly relevant to the 188 
aims of this study. 189 
Psychological Distress 190 
The Depression, Anxiety, Stress Scale 21 (DASS-21; Lovibond & Lovibond, 1995) assesses 191 
levels of depression, anxiety and stress. The items consist of statements referring to the 192 
past week, rated on a 4-point scale. Scores on each subscale range from 0 to 42 with higher 193 
scores indicating greater distress. The DASS-21 has strong psychometric properties (Brown 194 
et al., 1997).  195 
Food Anxiety 196 
The Food Neophobia Scale (FNS; Pliner & Hobden, 1992) is a ten-item scale that measures 197 
willingness to try new foods. Scores above 35 are considered high, with lower scores 198 
indicating greater willingness to try unfamiliar foods (Pliner & Hobden, 1992). The scale has 199 
been validated numerous times and is the standard measure of food neophobia, with good 200 
reliability and validaty (Miselman, King & Gilette, 2010). At present no appropriate 201 
measures of food anxiety have been developed. The FNS was chosen as the best available 202 
tool to measure anxiety around new foods.  203 
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Disordered Eating 204 
Two questionnaires were used to target the differing attitudes and behaviours surrounding 205 
disordered eating, to account for any overlap in disordered eating categories (Eddy et al., 206 
2008; Swanson et al., 2011).   207 
The Eating Attitudes Test (EAT-26; Garner & Garfinkel, 1979) is used to assess eating 208 
disorder risk by measuring the attitudes and behaviours suggestive of Anorexia and Bulimia 209 
Nervosa. It has been used to identify eating disturbances in non-clinical samples.  It is used 210 
as a screening tool for eating disorders, but is not a diagnostic tool. The items are scored on 211 
a 3-point scale, with a score of 20 or above requiring further evaluation. The tool has strong 212 
psychometric properties (Garner et al., 1982) and has been used in populations with dietary-213 
controlled conditions (Guthrie, Creed & Whorwell, 1990) . Confirmatory factor analysis found 214 
poor support for Garner et al.’s (1982) three-factor model (RCFI=.889, RMSEA=.075),  215 
strongest support was found for a one factor model (RCFI=.922, RMSEA=.066). Therefore, 216 
total EAT-26 scores were used throughout the analysis and subscales were not explored.  217 
The Binge Eating Scale (BES; Gormally et al., 1982) assesses the behavioural aspects of binge 218 
eating and the thoughts and feelings associated with these behaviours. The BES is a 219 
screening tool to help identify individuals who may be at risk for binge eating behaviours. 220 
Scores on the BES range from 0-46, with scores above 17 indicating moderate bingeing and 221 
scores greater than 27 indicating severe binging. The BES has been validated in both obese 222 
and non-obese population and used in those with gastrointestinal disorders (Duarte, Pinto-223 
Gouveia & Ferreira, 2015; Passananti et al., 2013; Timmerman, 1999).  224 
 225 
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Ethical Approval 226 
Ethical approval was granted by the Psychology Research Ethics Committee, University of 227 
Birmingham.  228 
Statistical Analysis 229 
Data was analysed using the Statistics for the Social Sciences (SPSS) version 22.0. 69 coeliac 230 
disease participants were excluded across the groups due to the absence of a biopsy-proven 231 
diagnosis. Overall, 77 individuals were removed from the coeliac disease group, 27 from 232 
type two diabetes and 9 from inflammatory bowel disease and 4 from health controls, 233 
providing 503 participants for analysis. 234 
To assess the predictors of disordered eating, regression analyses were conducted to 235 
examine the relationships between disease specific factors, disease non-specific factors and 236 
disordered eating scores and to compare these amongst the different diagnostic categories. 237 
Correlations were run between BES and EAT-26 scores and all other variables to select 238 
covariates for the regression models. The covariates and nonspecific predictors were added 239 
into stage one of the hierarchical regression, followed by disease specific predictors (dietary 240 
management, gastrointestinal symptoms). All variables were centered before being entered 241 
into the regression models. Bonferroni corrections were used to control for multiple 242 
comparisons and reduce the chance of type one errors (Armstrong, 2014). 243 
The fit of the model across the groups was assessed using three stages: 1) does the 244 
predictor set work better for coeliac disease than other groups; 2) are the models 245 
substitutable and 3) are the regression weights across the groups different. 1) Fishers Z test 246 
was used to compare the R2 values from each of the groups regression models. A significant 247 
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p-value (<.05) would indicate a difference in model fit across the groups. 2) Differences in 248 
model structure across the diagnostic groups were explored using a cross validation 249 
technique (Palmer & O’Connell, 2009). The regression model from each group was applied 250 
to every other group (e.g. the coeliac disease regression model was applied to all other 251 
diagnostic groups) to create both a “direct” and a “crossed” model. The resulting crossed R2 252 
and direct R2 were compared using Hotelling’s t-test, a significant p-value (<.05) indicates a 253 
difference in model structure across the groups, which requires further investigation. 3) To 254 
examine the individual predictors within the models, regression weights across the groups 255 
were compared.   256 
To investigate the types of eating behaviours, a two-step cluster analysis was performed on 257 
the coeliac disease sample. Three theoretical groups were hypothesised to come out of the 258 
analysis (two disordered and a healthy type) so specified three groups to emerge from the 259 
analysis. Years with diagnosis, psychological distress, disordered eating scores, Food 260 
Neophobia scores, dietary-management and gastrointestinal symptoms were entered into 261 
the analysis.  Variables with a predictor importance less than 0.2 were subsequently 262 
removed from the analysis. The average silhouette measure of cohesion and separation 263 
(ranging from -1 to +1) was used to determine the goodness of model fit. A silhouette 264 
measure <0.2 is considered poor, between 0.2 and 0.5 is considered a fair solution and >0.5 265 
is considered a good solution (Mooi & Sarstedt, 2011).  266 
Results 267 
Overall, 72.8% of participants identified as White British, 18.6% as White Other, 2% as Asian, 268 
1% as Black and 2.8% as Mixed Background. Table 1 displays the mean age, Body Mass Index 269 
(BMI) and years since diagnosis across the groups. The type two diabetes group were older 270 
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and had a higher BMI when compared to other diagnostic groups. There were no other 271 
differences between the groups. The BMI, ethnicity and years with diagnosis for each 272 
condition were similar to previous samples; however, across all groups our samples were 273 
younger than previous reports (Hauser et al., 2010; Koro, Bowlin, Bourgeois & Fedder, 2004; 274 
Wada et al., 2015).  275 
68.5% of participants with coeliac disease reported that they followed their GFD “all the 276 
time”.  Of the remaining 31.5%, 9.4% were completely non-adherent and 22.1% were 277 
partially adherent to the GFD 278 
Table 1 279 
Demographic Information (Age, Body Mass Index, Years with Condition) Displayed as Means 280 
and Standard Deviations. Ethnicity Displayed as Number and Percentage.  281 
 Coeliac 
Disease  
(n=157) 
Inflammatory 
Bowel 
Disease  
(n=116) 
Type Two 
Diabetes  
(n=88) 
Healthy 
Controls  
(n=142) 
Group 
Differences 
Age 
(years) 
38 (13.4) 36 (11.98) 47 (12.83) 33 (13.72) T2D > CD, 
IBD, HC 
Body Mass 
Index 
22.91 (3.83) 23.05 (4.91) 29.13 (3.63) 22.39 (4.75) T2D > CD, 
IBD, HC 
Years since 
Diagnosis 
9 (10.25) 8 (7.62) 9 (7.29) -  CD= IBD= 
T2D 
Ethnicity 
(White) 
150 (95.5) 108 (93.1) 84 (95.5) 133 (93.0) CD= IBD= 
T2D= HC 
Ethnicity (Non-
White) 
7 (4.5) 8 (6.9) 4 (4.5) 10 (7.0) CD= IBD= 
T2D= HC 
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CD: Coeliac disease; T2D: Type Two Diabetes; IBD: Inflammatory Bowel Disease; HC: Healthy 282 
Controls. Standard deviations are displayed in brackets (for ethnicity, percentage is 283 
displayed in brackets).  284 
Prevalence of Disordered Eating in Coeliac Disease compared to Controls 285 
Table two displays the proportion of participants scoring above the clinical cut-off for the 286 
EAT-26 and the BES and the mean total scores for each group. The Kruskal Wallis tests found 287 
significant differences in mean EAT-26 scores across the diagnostic groups (H(3)=31.84, 288 
p<.001). EAT-26 scores were higher in those with coeliac disease than healthy controls 289 
(U=5312.5, p=.001) and those with coeliac disease scored higher than those with type two 290 
diabetes (U=2532, p=.001). There was a significant difference in BES scores across the 291 
diagnostic groups (H(3)=82.41, p<.001). Those with coeliac disease had higher BES scores 292 
than healthy controls (U=3947, p<.001) but scored lower than those with type two diabetes 293 
(U=2268, p=.001).294 
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Table 2 295 
Mean Scores and Percentage scoring above the clinical cut-offs for measures of disordered eating 296 
Measure Coeliac 
Disease  
(n=157) 
Type Two 
Diabetes 
(n=88) 
Inflammatory 
Bowel Disease 
(n=116) 
Healthy 
Controls 
(n=142) 
Group Differences 
Eating Attitudes 
Test (>20) 
11.1 (15.7%) 7.4 (8.8%) 12.8 (20%) 7.7 (3.8%) CD > T2D, HC; IBD > T2D, HC 
Binge Eating Scale 
(>17) 
11.2 (19.4%) 13.6 (25%) 9.9 (22.2%) 3.9 (2.3%) CD, T2D, IBD > HC 
CD: Coeliac disease; T2D: Type Two Diabetes; IBD: Inflammatory Bowel Disease; HC: Healthy Controls.  297 
The number in brackets represents the percentage of participants scoring above the pre-determined clinical cut-offs for the Binge Eating Scale 298 
and Eating Attitudes Test-26. EAT-26 and BES scores were compared across all groups (p<.05; see group differences column).299 
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Predictors of Disordered Eating  300 
 Strong associations (p<.008) were found for scores on the EAT-26 and BES, and measures of 301 
psychological distress, as well as age, BMI, symptoms and GFD management. These factors 302 
were added as covariates. Based on the significant relationships with disordered eating and 303 
between the subscales, total DASS-21 scores were entered into step one of the regression 304 
model. Years with condition, BMI and age were also added. This model accounted for 23.1% 305 
of the variance in EAT-26 scores  (F=(4, 90)=8.36, p<.001; see Table 3) with distress having a 306 
significant positive regression weight.  307 
The disease specific variables were entered in step two (dietary-management and 308 
gastrointestinal symptoms). For the coeliac disease group, when predicting EAT-26 score, 309 
this model accounted for 54.3% of the variance in EAT-26 scores (F=(6, 90)=20.42, p<.001; 310 
see Table 3) with dietary-management and gastrointestinal symptoms having significant 311 
positive regression weights. Based on the examination of ß weights, dietary-management 312 
has the major contribution.  313 
The overall model predicted total EAT-26 score equally well for all of the diagnostic groups. 314 
Comparison of the fit of the model across those with type two diabetes (z=2.87,p=.004) and 315 
inflammatory bowel disease (z=6.12,p<.001) revealed that there was no significant 316 
difference between the respective R2 values for the EAT-26 score.  317 
When examining the model structure across the groups, structural differences were found. 318 
When looking at coeliac disease and inflammatory bowel disease, the combined direct R2 = 319 
.60 and crossed R2 = .40 were significantly different (z=2.87,p=.004). There are structural 320 
differences between the best regression model for predicting EAT-26 score in those with 321 
coeliac disease and inflammatory bowel disease. When looking at coeliac disease and type 322 
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two diabetes together, the combined direct R2 = .60 and crossed R2 = -.43 were significantly 323 
different (z=6.12,p<.001), indicating that there are structural differences between the best 324 
regression model for predicting EAT-26 score in those with coeliac disease and type two 325 
diabetes.  326 
Further analysis revealed that dietary self-management (z=3.62, p<.001) and DASS-21 scores 327 
(z=-2.80, p=.006) had significantly different regression weights in the coeliac disease and 328 
inflammatory bowel disease groups, with dietary-management having more influence on 329 
EAT-26 scores in those with coeliac disease and DASS-21 scores in those with inflammatory 330 
bowel disease. Dietary self-management (z=4.60 p<.001) had a significantly different 331 
regression weight in the coeliac disease and type two diabetes groups, with poor dietary 332 
self-management being associated with  EAT-26 scores in those with coeliac disease. The 333 
regression weights for gastrointestinal symptoms were close to significance across coeliac 334 
disease and type two diabetes (z=1.90, p=.057). The regression models for the comparison 335 
groups are provided in the supplementary materials for comparison but are not central to 336 
the aims of the research.  337 
 338 
 339 
 340 
 341 
 342 
 343 
 344 
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Table 3 345 
Disease specific and Non-Specific Factors in Predicting EAT-26 Scores in Coeliac Disease 346 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors  
Age -.02 -.03    
Body Mass Index -.24 -.12    
Years with Condition .01 .08    
DASS-21 .21 .04* .26 8.36* .26* 
Model 2) Disease Specific Factors  
Age .02 .03    
Body Mass Index -.11 -.06    
Years with Condition .05 .06    
DASS-21 .09 .22    
Gastrointestinal 
Symptoms 
.65 .50*    
Dietary-management 2.52 .24* .57 20.42* .31* 
* = significance at p<.008. The significance of the F value refers to the F associated with each 347 
step.  348 
For the coeliac disease group, when predicting BES score, collectively this model (disease 349 
non-specific factors) accounted for 41.8% of the variance in BES scores (F=(4,86)=17.53, 350 
p<.001; see table 4) with distress having a significant positive  regression weight. The 351 
addition of disease-specific factors only explained no additional variance.  352 
The overall model fit all of the diagnostic groups equally well. Comparison of the fit of the 353 
disease-nonspecific model across those with type two diabetes (z=-1.33,p=.180) and 354 
inflammatory bowel disease (z=0.64,p=.521) revealed no significant difference between the 355 
respective R2 values for BES scores between inflammatory bowel disease, type two diabetes 356 
and coeliac disease. These predictors do equally well across the groups. Examination of ß 357 
DISORDERED EATING IN COELIAC DISEASE  
19 
 
weights found a positive association between depression and BES scores across all of the 358 
groups.  359 
Table 4 360 
Disease specific and Non-Specific Factors in Predicting BES Scores in Coeliac Disease 361 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors 
Age -.13 -.14    
Body Mass Index .71 .23    
Years with Condition -.07 -.06    
DASS-21 .33 .51* .44 17.53* .44* 
Model 2) Disease Specific Factors 
Age -.13 -.15    
Body Mass Index .69 .22    
Years with Condition -.09 -.07    
DASS-21 .35 .55*    
Gastrointestinal 
Symptoms 
-.14 -.07    
Dietary-management -.34 -.02 .67 11.61* .00 
* = significance at p<.008. The significance of the F value refers to the F associated with each 362 
step.  363 
Typologies of Eating Attitudes and Behaviour in Coeliac Disease 364 
Three groups emerged from the cluster analysis producing a “fair” model with a silhouette 365 
measure of cohesion and separation of 0.5 (Mooi & Sarstedt, 2011). The first group was the 366 
largest (N=60) containing those with low psychological distress, few gastrointestinal 367 
symptoms, good dietary-management and low scores on all disordered eating measures. 368 
These were determined to be the “low risk” group. The second group contained 25 369 
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participants. This group was named the “critical” group. These individuals’ scored high on 370 
EAT-26, and reported poor dietary self-management, many gastrointestinal symptoms and 371 
moderate stress scores. The “high distress” group included 11 individuals with high BES 372 
scores; this group scored highest on all measures of psychological distress but show good 373 
dietary-management.  The Kruskal Wallis tests found significant differences in all variables 374 
across the three groups (see Table 5). Further post-hoc Mann-Whitney tests revealed that 375 
when the critical group and the high distress group were compared to the low risk group, 376 
significant differences were found across all of the variables (p<.05).  377 
Table 5 378 
Cluster Analysis in Individuals with Coeliac Disease 379 
Variable Low Risk (60) Critical (25) High Distress (11) 
Depression (0-14) 1.72 5.4 12 
BES Total (0-46) 6.58 11.44 39 
Stress (0-17) 3.57 8.72 14.45 
GFD Management 
(Always-Never) 
Always Most of the time Always 
EAT-26 Total (10-
40) 
8.3 18.96 10.36 
Gastrointestinal 
Symptoms (0-15) 
7.13 11.72 13.82 
GFD, gluten-free diet; BES, Binge Eating Scale; EAT-26, Eating Attitudes Test-26 380 
Surprisingly, years with diagnosis had a predictor importance less than 0.2 and was 381 
subsequently removed from this cluster analysis. We calculated the age of diagnosis and 382 
divided this into adult diagnosis, childhood diagnosis and less than 4 years. However, the 383 
sample sizes were too small to conduct further analysis. 384 
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Discussion 385 
The primary goal of this study was to explore the prevalence, predictors and types of 386 
disordered eating in coeliac disease, inflammatory bowel disease, type two diabetes and 387 
healthy controls, and examine whether factors unique to the diagnosis of coeliac disease 388 
contributed to reports of disordered eating above the impact of having a dietary-controlled 389 
health condition.  390 
This study used two screening tools for disordered eating, measuring a combination of 391 
disordered eating attitudes and self-reported behaviours. Our findings were consistent with 392 
previous research; the prevalence of disordered eating as assessed by the EAT-26 was 393 
greater in coeliac disease compared to healthy controls, with 15.7% scoring above the 394 
clinical cut-off. This is lower than previous reports of 22-29% but significantly higher than 395 
healthy controls (Arigo, Anskis & Smyth, 2012; Karwautz et al., 2008).  396 
Uniquely, our research compared the prevalence of disordered eating across dietary-397 
controlled health conditions.  Of those with inflammatory bowel disease, 20% scored above 398 
the cut-off on the EAT-26, with no significant differences in prevalence scores between 399 
inflammatory bowel disease and coeliac disease. Individuals with dietary-controlled 400 
gastrointestinal conditions may be placed at a unique risk for the development of Anorexic-401 
type attitudes and behaviours. We do not know the nature of these associations, however, 402 
the presence of gastrointestinal symptoms may be important in the development of 403 
disordered eating in those with gastrointestinal disease (Tang et al., 1997). It is not clear 404 
how gastrointestinal symptoms are associated with disordered eating but potential 405 
mechanisms may include accidental or intentional gluten ingestion, which is consistent with 406 
the model of disordered eating in gastrointestinal disease (Satherley, Howard & Higgs, 407 
2014). Case reports indicate that for some individuals with gastrointestinal disease, their 408 
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prescribed dietary-regimen may interact with disordered eating; the consumption of foods 409 
that trigger gastrointestinal symptoms may be used to promote weight loss (Leffler et al., 410 
2007; Yucel et al., 2006). Furthermore, larger studies in coeliac disease have found 411 
associations between disordered eating scores and dietary transgressions (Wagner et al., 412 
2015). A similar phenomenon has been described in type one diabetes, where individuals 413 
may withhold insulin to promote weight loss (Jones, Lawson, Daneman, Olmsted & Rodin, 414 
2000). Future research should focus on the role of gastrointestinal symptoms, dietary-415 
management and disordered eating in coeliac disease.  416 
Our research has identified specific factors that are associated with disordered eating in 417 
coeliac disease. In coeliac disease, disease specific factors explained additional variance in 418 
EAT-26 scores (29.7%) when compared to disease-nonspecific factors, and dietary 419 
management was only important for the coeliac disease group. In line with previous 420 
research, poor dietary self-management explained addition variance in EAT-26 scores for 421 
those with coeliac disease  (Arigo, Anskis & Smyth 2012; Karwautz et al., 2008; Wagner et 422 
al., 2015). In addition, distress was associated with EAT-26 scores in coeliac disease, 423 
however, distress scores were no longer significant when accounting for gastrointestinal 424 
symptoms and dietary management in coeliac disease. Furthermore, the cluster analysis 425 
produced a “critical” group who scored high on the EAT-26 but reported poorer dietary self-426 
management. This suggests that a small group of individuals with coeliac disease may have a 427 
difficult relationship with food.  Some individuals may engage in poor dietary self-428 
management in order to promote villous atrophy and subsequent weight loss (Leffler et al., 429 
2007). This offers one interpretation of our results; however, the self-reported measures of 430 
dietary self-management and the motivations behind poor management are unclear.  431 
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When compared with healthy controls, all dietary-controlled diagnostic groups had 432 
increased scores on the BES. Binge eating is commonly reported in those with type two 433 
diabetes, so it is unsurprising that those with type two diabetes scored highest on these 434 
measures (Crow, Kendall, Praus & Thuras, 2001). Binge eating has not previously been 435 
reported in those with coeliac disease. In the United Kingdom, it has been reported that up 436 
to 81% of individuals gain weight after commencing the GFD (Dickey & Kearney, 2006). This 437 
weight gain has been attributed to factors including the poor nutritional quality of some 438 
gluten-free foods, resulting in an increased energy intake, and intestinal recovery (Garcia-439 
Manzanares & Lucendo, 2011; Kabbani et al., 2012); however for a subset of individuals, our 440 
results suggest that binge eating may also play a role in weight gain. Future research should 441 
focus on the relationship between binge eating and weight changes in coeliac disease.  442 
Factors common to all conditions (years with condition, psychological distress) were more 443 
strongly associated with BES scores across all diagnostic groups. Binge eating in coeliac 444 
disease may be influenced by distress associated with the presence of a long-term 445 
condition. Greater psychological distress has frequently been associated with binge eating 446 
behaviours (Dide & Fitzgibbon, 2005). Furthermore, the cluster analysis highlighted a “High 447 
Distress” group who were characterised by increased BES scores and psychological distress. 448 
Alternatively, following a restricted dietary regimen, like the GFD, may increase the risk of 449 
binge eating behaviours through disinhibition (Herman & Polivy, 1985).  450 
Limitations and Future Research 451 
The cross-sectional nature of this study limits any conclusions about the sequence of events 452 
between disordered eating and coeliac disease diagnosis. Longitudinal studies are essential 453 
in determining the timeframe between disordered eating onset and coeliac disease 454 
diagnosis. Furthermore, we recognise that online recruitment may create a bias in sampling 455 
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which may over/under-inflate problems with eating behaviors and dietary self-456 
management. In addition, our samples were younger than those previously reported across 457 
all conditions. This may be due to the nature of online sampling, which is likely to attract a 458 
younger population (Remillard et al., 2014). Despite these limitations, this study provides an 459 
important extension in exploring disordered eating in those with coeliac disease and online 460 
methods allowed recruitment of a large sample. 461 
Due to the nature of online data collection, coeliac disease diagnosis, dietary management, 462 
disordered eating scores and psychological distress were all based on self-report. These 463 
findings need replication in a biopsy-confirmed sample of individuals with coeliac disease 464 
and should focus on more objective measures of dietary-management such as anti-tissue 465 
transglutaminase assays, questionnaires designed to assess gluten-free dietary management 466 
(Leffler et al., 2009) and multi-modal approaches, including self-report and dietician 467 
assessment. However, the comparison across different chronic health conditions, recruited 468 
in the same manner, is a strength of this study and provides an extension of existing 469 
research in coeliac disease and disordered eating.  470 
No evidence was found for the role of anxiety in the development of disordered eating 471 
behaviours. Surprisingly the FNS was not a good predictor of disordered eating. We had 472 
anticipated that FNS scores might tap into fears about cross-contamination and trying new 473 
foods. However, the FNS may lack sensitivity to assess this mechanism in those with coeliac 474 
disease. The development of a scale measuring food anxiety in coeliac disease may allow 475 
further investigation of the role of anxiety around food in disordered eating in coeliac 476 
disease. 477 
Clinical Implications  478 
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The observation that individuals with dietary-controlled chronic health conditions have 479 
increased scores in disordered eating tools when compared to healthy controls suggesting 480 
that the use of screening tools for disordered eating may be valuable in these individuals. 481 
More specifically, the observation that gastrointestinal symptoms and dietary management 482 
were associated with EAT-26 scores in coeliac disease, indicates that individuals 483 
experiencing difficulties in managing their gluten-free diet and reporting gastrointestinal 484 
symptoms may benefit from have their eating attitudes and behaviors explored. In addition, 485 
for those who do score above clinical cut-offs, it is important to consider how their chronic 486 
health condition may interact with disordered eating attitudes and behaviours. 487 
Conclusions 488 
Our research indicates factors both common to all dietary-controlled health conditions 489 
(psychological distress), gastrointestinal symptoms and factors unique to the coeliac disease 490 
diagnosis (GFD management) require further assessment in relation to coeliac disease and 491 
disordered eating.  492 
A small group of people with coeliac disease display poor dietary management and this is 493 
associated with disordered eating attitudes and beliefs, lending some support to models of 494 
disordered eating in gastrointestinal disorders (Satherley, Howard & Higgs, 2014). The 495 
majority of individuals with coeliac disease display a typical eating pattern, but for some, 496 
disordered eating behaviours are a feature of their coeliac disease. We have isolated some 497 
factors that are specific to coeliac disease that may place individuals at increased risk for 498 
disordered eating attitudes and behaviours. Future research should focus on understanding 499 
this sub-group of individuals with coeliac disease and look at ways to identify them and 500 
provide support.  501 
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